One of the best biotech stocks this year is positioned to cash in on the convergence of two major trends in the biotech industry.
This convergence could propel the stock to gains of as much as 130% in the next 12 months.
Here's everything you need to know to cash in on these profitable trends...
Tags:biotech stocks
To get full access to all Money Morning content, click here
About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.
Disclaimer:© 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
The post One of the Best Biotech Stocks of 2017 Could See 130% Gains This Year appeared first on Money Morning - We Make Investing Profitable.